New Oxoid Chromogenic Medium Improves Screening For MRSA
Fast and accurate screening is extremely important for infection control programmes to be effective. The speed of detection using Oxoid Chromogenic MRSA Agar allows colonised patients to be targeted promptly for isolation and appropriate treatment, helping to minimise opportunities for transmission at the earliest opportunity. The accuracy of the new Oxoid medium helps to ensure that costly resources are targeted towards those who need it, especially in hospitals where the MRSA rate is high.
The chromogen in Oxoid Chromogenic MRSA Agar detects phosphatase activity, which is present in MRSA strains, producing distinct, easily visible, denim-blue colonies. Antimicrobial compounds within the medium, including cefoxitin, inhibit the growth of competitor organisms to allow accurate diagnosis of MRSA.
The medium may be inoculated directly from swabs, or from isolates or culture suspensions. The plate can then be examined for MRSA colonies after a short, 18-hour incubation.
In a comparative evaluation with four other commercially available chromogenic media and Oxacillin Resistance Screening Agar (ORSA), the Oxoid Chromogenic MRSA Agar produced the best results at 18 hours and gave excellent colour differentiation1.
For further information about Oxoid Chromogenic MRSA Agar, please telephone +44 (0)1256 841144, email val.kane@oxoid.com or visit http://www.oxoid.com
References:
1 Hutchinson, M. J., Edwards, G. F. S., Morrison, D., "Evaluation of chromogenic MRSA selective screening media," poster by Scottish MRSA Reference Laboratory presented at the 2005 Institute of BioMedical Sciences Annual Conference.
http://www.oxoid.com
Nou test cromogenic Oxoid mediu îmbunãtãþeºte screening-ul pentru SAMR - New Oxoid Chromogenic Medium Improves Screening For MRSA - articole medicale engleza - startsanatate